Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Urine Test Detects Legionella

By LabMedica International staff writers
Posted on 27 Mar 2013
The test is a single use capture immunoassay to detect Legionella pneumophila serogroup 1 in human urine specimens and consists of a conjugate tube, a test strip, and sample diluent/negative control. More...


Scientists at The Regional Laboratory of Public Health, (Haarlem, The Netherlands) evaluated an immunochromatographic urine antigen test (ICT) on 213 frozen urine samples that were unconcentrated from a sample collection of patients with and without LD that were collected between 2000 and 2011. They compared the results of the assay with another commercial test.

The test, called the TRU Legionella assay, has a conjugate tube containing a lyophilized bead of colloidal gold-linked polyclonal antibody to L. pneumophila serogroup 1 detector antibody. The test strip carries a nitrocellulose membrane with dried capture antibodies placed at a designated test line for Legionella. The test strip holder caps the conjugate tube during testing and subsequent disposal to reduce exposure to potential pathogens.

The sensitivity and specificity of the Meridian TRU Legionella assay (Meridian Bioscience; Cincinnati, OH, USA) were compared with the test results obtained by the widely used ICT assay, the Binax NOW urinary antigen test (Binax; Portland, ME, USA). Both antigen tests were performed simultaneously and the results were interpreted at 15 minutes for the Binax NOW test and at 20 minutes for Meridian TRU Legionella strip. To investigate if a prolonged incubation time would affect the sensitivity, the samples were also read at 30, 45, and 60 minutes of incubation.

The sensitivity was estimated as 73.3% for the Meridian TRU Legionella test and 76.3% for the Binax NOW urine antigen test. The specificity was 100% for both assays. There were five samples, which were positive in the Binax NOW and negative in the Meridian TRU Legionella test, and those five samples were all positive in an enzyme immunoassay-control test. After a prolonged incubation, the same five samples were also positive in the Meridian TRU Legionella test. When the tests were re-examined after 60 minutes of incubation the sensitivity of the Meridian TRU Legionella test increased to 80.6 % and to 81.3 % for the Binax NOW urine antigen test.

The authors concluded that both assays evaluated have similar performance characteristics and are suitable for the detection of L. pneumophila antigen in urine from patients suspected of having LD. As the prolongation of incubation does not affect the specificity, it is recommended that an incubation time longer than that recommended by the manufacturer be used routinely. The study was published in the March 2013 issue of the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:

Dutch Regional Laboratory of Public Health
Meridian Bioscience
Binax



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.